top of page

LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for EB

Updated: Jul 31, 2023

This Special call will seek innovative proposals to develop therapeutics for severe unmet needs that can be brought rapidly to EB patients: as such, there will be a strong focus on repurposing well-evidenced therapeutics towards clinical testing, to deliver:

  • Increased resolution of non-healing wounds

  • Prevention and/or reduction of chronic inflammation

  • Inhibition and/or reduction of fibrosis

  • Decreased risk of squamous cell carcinoma (SCC) initiation in EB

The funding round will be organised in a two-stage application process, with an EOI submission in the summer.

Main deadlines

Application Step


Call for EOI opens

10 July 2023

Deadline for EOI submission

10 September 2023

Shortlisted EOI applicants invited to submit full applications; Call for full applications opens

04 October 2023

Deadline for full application submission

04 December 2023

Funding decision, and sucessful applicants notified of outcome

By 01 April 2024

Project start

By 01 July 2024

All details, EOI application template & guidance document for submission are provided on LifeArc's joint call website.

26 views0 comments


bottom of page